Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 78 checked references that resolve
resolves10.1038/nm.2505Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut
resolves10.1038/nri2378Vitamin effects on the immune system: vitamins A and D take centre stage
resolves10.1084/jem.170.4.1415Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production.
resolves10.1016/j.immuni.2014.03.012Macrophage-Restricted Interleukin-10 Receptor Deficiency, but Not IL-10 Deficiency, Causes Severe Spontaneous Colitis
resolves10.1016/j.immuni.2011.03.018Interleukin-10 Signaling in Regulatory T Cells Is Required for Suppression of Th17 Cell-Mediated Inflammation
resolves10.1016/j.immuni.2011.01.020Th17 Cells Express Interleukin-10 Receptor and Are Controlled by Foxp3− and Foxp3+ Regulatory CD4+ T Cells in an Interleukin-10-Dependent Manner
resolves10.1038/ni904Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
resolves10.1084/jem.20030152Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor <i>Foxp3 </i>
resolves10.4049/jimmunol.0802535A Central Role for Induced Regulatory T Cells in Tolerance Induction in Experimental Colitis
resolves10.1016/j.intimp.2010.11.034The effects of Foxp3-expressing regulatory T cells expanded with CD28 superagonist antibody in DSS-induced mice colitis
resolves10.1002/ibd.21769B Cells Exposed to Enterobacterial Components Suppress Development of Experimental Colitis
resolves10.1016/j.jaut.2014.01.032IL-10-producing regulatory B cells induced by IL-33 (BregIL-33) effectively attenuate mucosal inflammatory responses in the gut
resolves10.4049/jimmunol.1103354A Novel IL-10–Independent Regulatory Role for B Cells in Suppressing Autoimmunity by Maintenance of Regulatory T Cells via GITR Ligand
resolves10.1136/gut.2006.099861Prevention of experimental colitis by parenteral administration of a pathogen-derived immunomodulatory molecule
resolves10.1093/intimm/5.11.1461Phenotypically distinct subsets of CD4<sup>+</sup> T cells induce or protect from chronic intestinal inflammation in C. B-17 <i>scid</i> mice
resolves10.1016/S1074-7613(02)00274-1Chronic Intestinal Inflammatory Condition Generates IL-10-Producing Regulatory B Cell Subset Characterized by CD1d Upregulation
resolves10.4049/jimmunol.178.6.3447B Cell Regulation of CD4+CD25+ T Regulatory Cells and IL-10 Via B7 is Essential for Recovery From Experimental Autoimmune Encephalomyelitis
resolves10.1016/j.immuni.2011.11.019B Cell-Intrinsic MyD88 Signaling Prevents the Lethal Dissemination of Commensal Bacteria during Colonic Damage
resolves10.1186/1476-9255-2-13Reversal of experimental colitis disease activity in mice following administration of an adenoviral IL-10 vector
resolves10.1021/mp100331rTreatment of Mice with Dextran Sulfate Sodium-Induced Colitis with Human Interleukin 10 Secreted by Transformed<i>Bifidobacterium longum</i>
resolves10.1016/1074-7613(95)90157-4Abnormal B lymphocyte delevopment, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule
resolves10.1007/s10620-010-1240-3Induction and Activation of Adaptive Immune Populations During Acute and Chronic Phases of a Murine Model of Experimental Colitis
resolves10.1084/jem.184.6.2271Experimental Autoimmune Encephalomyelitis Induction in Genetically B Cell–deficient Mice
resolves10.1038/ni833B cells regulate autoimmunity by provision of IL-10
resolves10.4049/jimmunol.1001307Regulatory B Cells (B10 Cells) and Regulatory T Cells Have Independent Roles in Controlling Experimental Autoimmune Encephalomyelitis Initiation and Late-Phase Immunopathogenesis
resolves10.4049/jimmunol.1200936IL-10 Produced by Induced Regulatory T Cells (iTregs) Controls Colitis and Pathogenic Ex-iTregs during Immunotherapy
resolves10.1007/s10875-009-9345-1Foxp3+ Regulatory T Cells, Th17 Effector Cells, and Cytokine Environment in Inflammatory Bowel Disease
resolves10.1002/eji.201243154On the road to tolerance — Generation and migration of gut regulatory T cells
resolves10.1002/eji.200737296Reciprocal generation of Th1/Th17 and T<sub>reg</sub> cells by B1 and B2 B cells
resolves10.1002/eji.200838201Resting B cells expand a CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> Treg population <i>via</i> TGF‐β3
resolves10.4049/jimmunol.1100284Mice Lacking Endogenous IL-10–Producing Regulatory B Cells Develop Exacerbated Disease and Present with an Increased Frequency of Th1/Th17 but a Decrease in Regulatory T Cells
resolves10.1126/scitranslmed.3005407CD19
<sup>+</sup>
CD24
<sup>hi</sup>
CD38
<sup>hi</sup>
B Cells Maintain Regulatory T Cells While Limiting T
<sub>H</sub>
1 and T
<sub>H</sub>
17 Differentiation
resolves10.1165/rcmb.2011-0246OCRegulatory T Cells Induced by Mucosal B Cells Alleviate Allergic Airway Hypersensitivity
resolves10.4049/jimmunol.169.9.4712Cutting Edge: CD4+CD25+ Regulatory T Cells Suppress Antigen-Specific Autoreactive Immune Responses and Central Nervous System Inflammation During Active Experimental Autoimmune Encephalomyelitis
resolves10.4049/jimmunol.0904044TGF-β–Induced Myelin Peptide-Specific Regulatory T Cells Mediate Antigen-Specific Suppression of Induction of Experimental Autoimmune Encephalomyelitis
resolves10.1093/intimm/dxh029IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells
resolves10.1097/MIB.0b013e31829c32ddTherapeutic Evaluation of Ex Vivo-Generated Versus Natural Regulatory T-cells in a Mouse Model of Chronic Gut Inflammation
resolves10.1155/2014/973609CD20+ B Cell Depletion in Systemic Autoimmune Diseases: Common Mechanism of Inhibition or Disease-Specific Effect on Humoral Immunity?
resolves10.1002/ana.21363Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial
resolves10.1136/gut.2010.225482Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis
resolves10.1002/ibd.20215Exacerbation of ulcerative colitis after rituximab salvage therapy
resolves10.1136/gut.2007.138305Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves’ disease
resolves10.1053/gast.2003.50081Anti-CD2O chimeric monoclonal antibody (rituximab) treatment of immune-mediated thrombocytopenia associated with Crohn's disease
resolves10.3899/jrheum.100818Cytomegalovirus Colitis and Hypo-IgG After Rituximab Therapy for Rheumatoid Arthritis
resolves10.1007/BF01303184Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin
resolves10.1158/0008-5472.CAN-12-4184Anti-CD20 Antibody Promotes Cancer Escape via Enrichment of Tumor-Evoked Regulatory B Cells Expressing Low Levels of CD20 and CD137L
resolves10.1371/journal.pone.0054712Transient B-Cell Depletion with Anti-CD20 in Combination with Proinsulin DNA Vaccine or Oral Insulin: Immunologic Effects and Efficacy in NOD Mice
checked 2026-07-23 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.